Literature DB >> 832227

Regional intralymphatic infusion (ILI) of irradiated tumor cells with evidence of distant effects.

G J Juillard, P J Boyer, C H Yamashiro, H D Snow, T H Weisenburger, T McCarthy, R J Miller.   

Abstract

A case of canine lymphoma with radiographically-documented involvement of the para-aortic nodes is reported. Intralymphatic infusions (ILI) of cultured irradiated autochthonous tumor cells to remote lymph node bearing areas were associated with a dramatic initial shrinkage of the para-aortic lymphadenopathies. Three ILI timing schedules were used consecutively during a course of 10 treatments, allowing a comparison of responses in the same animal. The reported case suggests that a normal lymph node can be effectively "stimulated" by the same agent approximately every 3 weeks. A possible schedule for intralymphatic infusion is proposed for further investigation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 832227     DOI: 10.1002/1097-0142(197701)39:1<126::aid-cncr2820390122>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Intralymphatic infusion of interferon in patients with lymph nodal metastases from melanoma of the lower limbs.

Authors:  E Sulis; C Floris; C Massidda
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  New routes for allergen immunotherapy.

Authors:  Pål Johansen; Seraina von Moos; Deepa Mohanan; Thomas M Kündig; Gabriela Senti
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

Review 3.  Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.

Authors:  Charles B Smarr; Paul J Bryce; Stephen D Miller
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

4.  Intralymphatic immunotherapy.

Authors:  Gabriela Senti; Thomas M Kündig
Journal:  World Allergy Organ J       Date:  2015-03-07       Impact factor: 4.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.